AI2 Incubator spinout Modulus sells cell therapy tech assets to Boston’s Ginkgo Bioworks by Lisa Stiffler on April 2, 2024April 2, 2024 at 4:44 pm The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator, has sold its cell therapy platform assets to the Boston… Read More